Clinical Trials Browser

OTHER × Prostatic Neoplasms × Protein Subunit Vaccines × Clear all

NCT00694551 2019-10-04

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Phase NA Completed

29 enrolled 7 charts

Prostatic Neoplasms

NCT02452307 2017-08-17

Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

Phase 1/2 Unknown

Prostatic Neoplasms